Therapeutic Vaccines - Global Strategic Business Report

The global market for Therapeutic Vaccines was estimated at US$46.4 Billion in 2024 and is projected to reach US$117.1 Billion by 2030, growing at a CAGR of 16.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Therapeutic Vaccines market.

Global Therapeutic Vaccines Market - Key Trends and Drivers Summarized

Why Are Therapeutic Vaccines Garnering So Much Attention?

Therapeutic vaccines, designed to treat existing diseases by stimulating the immune system to fight off illness, have become a cornerstone in modern medicine. Unlike traditional vaccines that focus on preventing infections, therapeutic vaccines target ongoing diseases such as cancer, chronic infections, and autoimmune disorders. The increasing prevalence of cancer and the growing interest in immunotherapy as a viable treatment option are key drivers in this market. Therapeutic vaccines hold the promise of revolutionizing treatment for patients who have not responded to conventional therapies, making this a highly dynamic and rapidly growing segment within the broader vaccine market.

How Are the Various Segments of the Therapeutic Vaccines Market Expanding?

Notable segments include vaccines targeting infectious diseases like HIV and hepatitis, as well as autoimmune disorders. Technology plays a crucial role in the development of these vaccines, with advances in mRNA, dendritic cell-based vaccines, and viral vectors driving significant progress. The end-user segments primarily include hospitals, cancer treatment centers, and research institutions, which are playing an instrumental role in conducting clinical trials and early-phase research on novel therapeutic vaccines.

What Technological and Regulatory Trends Are Shaping the Market?

The therapeutic vaccine market has been greatly influenced by innovations in biotechnology, particularly with the rise of personalized medicine and next-generation sequencing. Advances in understanding the immune system and tumor biology have led to the development of vaccines that are highly specific to individual patients, driving the market's growth. Additionally, regulatory approvals for cancer vaccines, such as those targeting HPV and prostate cancer, have opened the door for further innovation in the field. Another key trend is the increasing collaboration between pharmaceutical companies and academic research institutes to accelerate vaccine development. Government initiatives and funding to support vaccine research are also providing a strong foundation for market growth.

What Are the Key Factors Driving Growth in the Therapeutic Vaccines Market?

The growth in the therapeutic vaccines market is driven by several factors, including the rising incidence of cancer and chronic infectious diseases, advancements in vaccine development technologies, and the growing number of clinical trials for therapeutic vaccines. Increased investments from pharmaceutical companies in R&D and the expansion of vaccine manufacturing infrastructure are critical drivers of market growth. Additionally, rising public awareness of immunotherapy and its potential benefits is fueling demand for therapeutic vaccines. Regulatory support in the form of fast-tracking approvals and orphan drug status for certain therapeutic vaccines is also contributing to market expansion. Finally, the global push for more effective cancer treatments is propelling significant growth in this market, especially as personalized vaccines gain traction.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Autoimmune Disease Vaccines segment, which is expected to reach US$62.8 Billion by 2030 with a CAGR of a 17.3%. The Neurological Disease Vaccines segment is also set to grow at 17.6% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $12.1 Billion in 2024, and China, forecasted to grow at an impressive 21.9% CAGR to reach $29.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Therapeutic Vaccines Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Therapeutic Vaccines Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Therapeutic Vaccines Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Agenus, Inc., Bavarian Nordic A/S, CEL-SCI Corporation, Dendreon Corporation, GlaxoSmithKline PLC and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 13 companies featured in this Therapeutic Vaccines market report include:

• Agenus, Inc.
• Bavarian Nordic A/S
• CEL-SCI Corporation
• Dendreon Corporation
• GlaxoSmithKline PLC
• Novartis International AG
• Oncothyreon, Inc.
• TVAX Biomedical Inc.
• Vical, Inc.

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

• Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
• Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
• Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
• Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
• Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
• Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
• Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.